These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8630287)

  • 1. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer.
    Díez M; Torres A; Maestro ML; Ortega MD; Gómez A; Pollán M; Lopez JA; Picardo A; Hernando F; Balibrea JL
    Br J Cancer; 1996 May; 73(10):1248-54. PubMed ID: 8630287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer.
    Diez M; Gomez A; Hernando F; Ortega MD; Maestro ML; Torres A; Mugüerza JM; Gutierrez A; Granell J; Balibrea JL
    Int J Biol Markers; 1995; 10(1):5-10. PubMed ID: 7629428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S; Shen L; Qian N; Chen K
    Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer.
    Picardo AL; Torres AJ; Maestro M; Ortega D; Garcia-Asenjo JA; Mugüerza JM; Hernando F; Diez M; Balibrea JL
    Cancer; 1994 May; 73(9):2305-11. PubMed ID: 8168034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
    Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance between serum and cytosolic levels of CEA, CA125 and SCC antigens in patients with non-small cell lung cancer.
    Diez M; Pollan M; Maestro ML; Ortega MD; Gomez A; Sanchez-Pernaute A; Torres A; Granell J; Balibrea JL
    Anticancer Res; 1995; 15(6B):2811-7. PubMed ID: 8669870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
    Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.
    Chen ZQ; Huang LS; Zhu B
    Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
    Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
    Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer.
    Niklinski J; Furman M; Laudanski J; Kozlowski M
    Eur J Cancer Prev; 1992 Oct; 1(6):401-6. PubMed ID: 1334443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
    Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients.
    Yu D; Du K; Liu T; Chen G
    Int J Mol Sci; 2013 May; 14(6):11145-56. PubMed ID: 23712355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
    Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
    Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M
    J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.